Biotech company Biogen have announced that they will file for official approval of a new Alzheimer’s drug, while results in clinical trials were uncertain.
Source link
Check Also
Medical News Today: Giving TB vaccine intravenously boosts efficacy
Experiments in rhesus macaques show that changing the mode of administration of an existing vaccine …